nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—kidney cancer	0.343	1	CbGaD
Bezafibrate—SLCO1B1—Pazopanib—kidney cancer	0.0816	0.226	CbGbCtD
Bezafibrate—CYP1A1—Erlotinib—kidney cancer	0.0427	0.118	CbGbCtD
Bezafibrate—CYP3A4—Everolimus—kidney cancer	0.0395	0.109	CbGbCtD
Bezafibrate—CYP2C8—Pazopanib—kidney cancer	0.0345	0.0957	CbGbCtD
Bezafibrate—CYP3A4—Temsirolimus—kidney cancer	0.0267	0.0739	CbGbCtD
Bezafibrate—CYP2C8—Erlotinib—kidney cancer	0.0246	0.0683	CbGbCtD
Bezafibrate—CYP2C8—Paclitaxel—kidney cancer	0.0226	0.0625	CbGbCtD
Bezafibrate—CYP2C8—Sorafenib—kidney cancer	0.02	0.0555	CbGbCtD
Bezafibrate—CYP3A4—Pazopanib—kidney cancer	0.014	0.0388	CbGbCtD
Bezafibrate—CYP3A4—Erlotinib—kidney cancer	0.01	0.0277	CbGbCtD
Bezafibrate—CYP3A4—Paclitaxel—kidney cancer	0.00915	0.0253	CbGbCtD
Bezafibrate—CYP3A4—Sorafenib—kidney cancer	0.00813	0.0225	CbGbCtD
Bezafibrate—CYP3A4—Vinblastine—kidney cancer	0.00803	0.0222	CbGbCtD
Bezafibrate—CYP3A4—Vincristine—kidney cancer	0.00789	0.0219	CbGbCtD
Bezafibrate—CYP3A4—Sunitinib—kidney cancer	0.00659	0.0182	CbGbCtD
Bezafibrate—PPARG—nephron—kidney cancer	0.00548	0.198	CbGeAlD
Bezafibrate—CYP3A4—Doxorubicin—kidney cancer	0.00493	0.0137	CbGbCtD
Bezafibrate—PPARG—Everolimus—Temsirolimus—kidney cancer	0.00266	1	CbGdCrCtD
Bezafibrate—CYP3A4—urine—kidney cancer	0.00196	0.0711	CbGeAlD
Bezafibrate—PPARA—renal system—kidney cancer	0.00195	0.0708	CbGeAlD
Bezafibrate—PPARA—kidney—kidney cancer	0.00189	0.0684	CbGeAlD
Bezafibrate—HMGCR—nephron tubule—kidney cancer	0.00143	0.0518	CbGeAlD
Bezafibrate—HMGCR—renal system—kidney cancer	0.0013	0.0471	CbGeAlD
Bezafibrate—HMGCR—kidney—kidney cancer	0.00126	0.0456	CbGeAlD
Bezafibrate—SLCO1B1—renal system—kidney cancer	0.00125	0.0451	CbGeAlD
Bezafibrate—HMGCR—cortex of kidney—kidney cancer	0.00122	0.0444	CbGeAlD
Bezafibrate—SLCO1B1—kidney—kidney cancer	0.0012	0.0436	CbGeAlD
Bezafibrate—HMGCR—gonad—kidney cancer	0.00117	0.0423	CbGeAlD
Bezafibrate—HMGCR—cardiac atrium—kidney cancer	0.00117	0.0422	CbGeAlD
Bezafibrate—PPARG—renal system—kidney cancer	0.00107	0.0389	CbGeAlD
Bezafibrate—PPARG—kidney—kidney cancer	0.00104	0.0376	CbGeAlD
Bezafibrate—Balsalazide—PTGS1—kidney cancer	0.000741	0.274	CrCbGaD
Bezafibrate—CYP2C8—renal system—kidney cancer	0.000709	0.0257	CbGeAlD
Bezafibrate—CYP2C8—kidney—kidney cancer	0.000685	0.0248	CbGeAlD
Bezafibrate—CYP1A1—renal system—kidney cancer	0.000654	0.0237	CbGeAlD
Bezafibrate—CYP1A1—kidney—kidney cancer	0.000632	0.0229	CbGeAlD
Bezafibrate—CYP1A1—cardiac atrium—kidney cancer	0.000586	0.0212	CbGeAlD
Bezafibrate—Clofibrate—CYP1A1—kidney cancer	0.000552	0.204	CrCbGaD
Bezafibrate—CYP3A4—renal system—kidney cancer	0.00048	0.0174	CbGeAlD
Bezafibrate—CYP3A4—kidney—kidney cancer	0.000464	0.0168	CbGeAlD
Bezafibrate—Balsalazide—PTGS2—kidney cancer	0.000423	0.157	CrCbGaD
Bezafibrate—Indomethacin—PTGS1—kidney cancer	0.000326	0.121	CrCbGaD
Bezafibrate—Anaemia—Dactinomycin—kidney cancer	0.000294	0.00188	CcSEcCtD
Bezafibrate—Erythema multiforme—Gemcitabine—kidney cancer	0.000293	0.00187	CcSEcCtD
Bezafibrate—Dizziness—Temsirolimus—kidney cancer	0.000292	0.00187	CcSEcCtD
Bezafibrate—Dyspepsia—Everolimus—kidney cancer	0.000289	0.00185	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000289	0.00185	CcSEcCtD
Bezafibrate—Alopecia—Vincristine—kidney cancer	0.000289	0.00185	CcSEcCtD
Bezafibrate—Blood creatinine increased—Capecitabine—kidney cancer	0.000289	0.00184	CcSEcCtD
Bezafibrate—Insomnia—Erlotinib—kidney cancer	0.000287	0.00183	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000287	0.00183	CcSEcCtD
Bezafibrate—Myalgia—Sunitinib—kidney cancer	0.000286	0.00183	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000285	0.00182	CcSEcCtD
Bezafibrate—Diarrhoea—Pazopanib—kidney cancer	0.000285	0.00182	CcSEcCtD
Bezafibrate—Liver function test abnormal—Capecitabine—kidney cancer	0.000284	0.00182	CcSEcCtD
Bezafibrate—Myocardial infarction—Paclitaxel—kidney cancer	0.000284	0.00181	CcSEcCtD
Bezafibrate—Infection—Sorafenib—kidney cancer	0.000284	0.00181	CcSEcCtD
Bezafibrate—Pain—Vinblastine—kidney cancer	0.000282	0.0018	CcSEcCtD
Bezafibrate—Constipation—Vinblastine—kidney cancer	0.000282	0.0018	CcSEcCtD
Bezafibrate—Constipation—Everolimus—kidney cancer	0.000281	0.0018	CcSEcCtD
Bezafibrate—Pain—Everolimus—kidney cancer	0.000281	0.0018	CcSEcCtD
Bezafibrate—Thrombocytopenia—Sorafenib—kidney cancer	0.000279	0.00178	CcSEcCtD
Bezafibrate—Dyspepsia—Erlotinib—kidney cancer	0.000279	0.00178	CcSEcCtD
Bezafibrate—Rash—Temsirolimus—kidney cancer	0.000279	0.00178	CcSEcCtD
Bezafibrate—Dermatitis—Temsirolimus—kidney cancer	0.000278	0.00178	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000277	0.00177	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000277	0.00177	CcSEcCtD
Bezafibrate—Headache—Temsirolimus—kidney cancer	0.000277	0.00177	CcSEcCtD
Bezafibrate—Dizziness—Pazopanib—kidney cancer	0.000275	0.00176	CcSEcCtD
Bezafibrate—Alopecia—Gemcitabine—kidney cancer	0.000274	0.00175	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—kidney cancer	0.000274	0.00175	CcSEcCtD
Bezafibrate—Infection—Sunitinib—kidney cancer	0.000273	0.00174	CcSEcCtD
Bezafibrate—Gastritis—Capecitabine—kidney cancer	0.000273	0.00174	CcSEcCtD
Bezafibrate—Muscular weakness—Capecitabine—kidney cancer	0.000272	0.00174	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000272	0.00174	CcSEcCtD
Bezafibrate—Pain—Erlotinib—kidney cancer	0.000271	0.00173	CcSEcCtD
Bezafibrate—Constipation—Erlotinib—kidney cancer	0.000271	0.00173	CcSEcCtD
Bezafibrate—Myalgia—Dactinomycin—kidney cancer	0.000271	0.00173	CcSEcCtD
Bezafibrate—Erythema—Gemcitabine—kidney cancer	0.00027	0.00172	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Vinblastine—kidney cancer	0.00027	0.00172	CcSEcCtD
Bezafibrate—Thrombocytopenia—Sunitinib—kidney cancer	0.000269	0.00172	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Everolimus—kidney cancer	0.000269	0.00172	CcSEcCtD
Bezafibrate—Influenza—Capecitabine—kidney cancer	0.000266	0.0017	CcSEcCtD
Bezafibrate—Anaemia—Vincristine—kidney cancer	0.000263	0.00168	CcSEcCtD
Bezafibrate—Rash—Pazopanib—kidney cancer	0.000263	0.00168	CcSEcCtD
Bezafibrate—Nausea—Temsirolimus—kidney cancer	0.000263	0.00168	CcSEcCtD
Bezafibrate—Dermatitis—Pazopanib—kidney cancer	0.000262	0.00168	CcSEcCtD
Bezafibrate—Abdominal pain—Vinblastine—kidney cancer	0.000261	0.00167	CcSEcCtD
Bezafibrate—Headache—Pazopanib—kidney cancer	0.000261	0.00167	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00026	0.00166	CcSEcCtD
Bezafibrate—Abdominal pain—Everolimus—kidney cancer	0.00026	0.00166	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Erlotinib—kidney cancer	0.000259	0.00166	CcSEcCtD
Bezafibrate—Infection—Dactinomycin—kidney cancer	0.000258	0.00165	CcSEcCtD
Bezafibrate—Pharyngitis—Paclitaxel—kidney cancer	0.000258	0.00165	CcSEcCtD
Bezafibrate—Urinary tract disorder—Paclitaxel—kidney cancer	0.000256	0.00164	CcSEcCtD
Bezafibrate—Bronchitis—Capecitabine—kidney cancer	0.000256	0.00164	CcSEcCtD
Bezafibrate—Urethral disorder—Paclitaxel—kidney cancer	0.000255	0.00163	CcSEcCtD
Bezafibrate—Thrombocytopenia—Dactinomycin—kidney cancer	0.000255	0.00163	CcSEcCtD
Bezafibrate—Pancytopenia—Capecitabine—kidney cancer	0.000253	0.00162	CcSEcCtD
Bezafibrate—Dyspepsia—Sorafenib—kidney cancer	0.000251	0.0016	CcSEcCtD
Bezafibrate—Abdominal pain—Erlotinib—kidney cancer	0.000251	0.0016	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00025	0.0016	CcSEcCtD
Bezafibrate—Anaemia—Gemcitabine—kidney cancer	0.00025	0.00159	CcSEcCtD
Bezafibrate—Insomnia—Sunitinib—kidney cancer	0.000248	0.00159	CcSEcCtD
Bezafibrate—Nausea—Pazopanib—kidney cancer	0.000247	0.00158	CcSEcCtD
Bezafibrate—Erythema multiforme—Paclitaxel—kidney cancer	0.000246	0.00157	CcSEcCtD
Bezafibrate—Pain—Sorafenib—kidney cancer	0.000244	0.00156	CcSEcCtD
Bezafibrate—Constipation—Sorafenib—kidney cancer	0.000244	0.00156	CcSEcCtD
Bezafibrate—Hypersensitivity—Vinblastine—kidney cancer	0.000243	0.00155	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Capecitabine—kidney cancer	0.000243	0.00155	CcSEcCtD
Bezafibrate—Myalgia—Vincristine—kidney cancer	0.000242	0.00155	CcSEcCtD
Bezafibrate—Hypersensitivity—Everolimus—kidney cancer	0.000242	0.00155	CcSEcCtD
Bezafibrate—Dyspepsia—Sunitinib—kidney cancer	0.000242	0.00154	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000237	0.00151	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000235	0.0015	CcSEcCtD
Bezafibrate—Pain—Sunitinib—kidney cancer	0.000235	0.0015	CcSEcCtD
Bezafibrate—Constipation—Sunitinib—kidney cancer	0.000235	0.0015	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Capecitabine—kidney cancer	0.000234	0.00149	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Sorafenib—kidney cancer	0.000233	0.00149	CcSEcCtD
Bezafibrate—Myocardial infarction—Capecitabine—kidney cancer	0.000233	0.00149	CcSEcCtD
Bezafibrate—Pruritus—Everolimus—kidney cancer	0.000233	0.00149	CcSEcCtD
Bezafibrate—Infection—Vincristine—kidney cancer	0.000231	0.00147	CcSEcCtD
Bezafibrate—Myalgia—Gemcitabine—kidney cancer	0.00023	0.00147	CcSEcCtD
Bezafibrate—Alopecia—Paclitaxel—kidney cancer	0.000229	0.00147	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000228	0.00146	CcSEcCtD
Bezafibrate—Thrombocytopenia—Vincristine—kidney cancer	0.000227	0.00145	CcSEcCtD
Bezafibrate—Urticaria—Sorafenib—kidney cancer	0.000227	0.00145	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—kidney cancer	0.000226	0.00144	CcSEcCtD
Bezafibrate—Erythema—Paclitaxel—kidney cancer	0.000226	0.00144	CcSEcCtD
Bezafibrate—Diarrhoea—Vinblastine—kidney cancer	0.000226	0.00144	CcSEcCtD
Bezafibrate—Abdominal pain—Sorafenib—kidney cancer	0.000226	0.00144	CcSEcCtD
Bezafibrate—Diarrhoea—Everolimus—kidney cancer	0.000225	0.00144	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Sunitinib—kidney cancer	0.000225	0.00143	CcSEcCtD
Bezafibrate—Pruritus—Erlotinib—kidney cancer	0.000224	0.00143	CcSEcCtD
Bezafibrate—Flatulence—Paclitaxel—kidney cancer	0.000223	0.00142	CcSEcCtD
Bezafibrate—Pain—Dactinomycin—kidney cancer	0.000222	0.00142	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—kidney cancer	0.000222	0.00142	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—kidney cancer	0.000221	0.00141	CcSEcCtD
Bezafibrate—Infection—Gemcitabine—kidney cancer	0.000219	0.0014	CcSEcCtD
Bezafibrate—Dizziness—Vinblastine—kidney cancer	0.000218	0.00139	CcSEcCtD
Bezafibrate—Dizziness—Everolimus—kidney cancer	0.000217	0.00139	CcSEcCtD
Bezafibrate—Muscle spasms—Paclitaxel—kidney cancer	0.000217	0.00139	CcSEcCtD
Bezafibrate—Abdominal pain—Sunitinib—kidney cancer	0.000217	0.00139	CcSEcCtD
Bezafibrate—Diarrhoea—Erlotinib—kidney cancer	0.000217	0.00139	CcSEcCtD
Bezafibrate—Thrombocytopenia—Gemcitabine—kidney cancer	0.000216	0.00138	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—kidney cancer	0.000215	0.00137	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000213	0.00136	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000212	0.00135	CcSEcCtD
Bezafibrate—Pharyngitis—Capecitabine—kidney cancer	0.000211	0.00135	CcSEcCtD
Bezafibrate—Urinary tract disorder—Capecitabine—kidney cancer	0.00021	0.00134	CcSEcCtD
Bezafibrate—Hypersensitivity—Sorafenib—kidney cancer	0.00021	0.00134	CcSEcCtD
Bezafibrate—Insomnia—Vincristine—kidney cancer	0.00021	0.00134	CcSEcCtD
Bezafibrate—Dizziness—Erlotinib—kidney cancer	0.00021	0.00134	CcSEcCtD
Bezafibrate—Anaemia—Paclitaxel—kidney cancer	0.000209	0.00133	CcSEcCtD
Bezafibrate—Urethral disorder—Capecitabine—kidney cancer	0.000209	0.00133	CcSEcCtD
Bezafibrate—Rash—Everolimus—kidney cancer	0.000207	0.00132	CcSEcCtD
Bezafibrate—Dermatitis—Everolimus—kidney cancer	0.000207	0.00132	CcSEcCtD
Bezafibrate—Headache—Vinblastine—kidney cancer	0.000207	0.00132	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—kidney cancer	0.000206	0.00132	CcSEcCtD
Bezafibrate—Headache—Everolimus—kidney cancer	0.000206	0.00132	CcSEcCtD
Bezafibrate—Abdominal pain—Dactinomycin—kidney cancer	0.000205	0.00131	CcSEcCtD
Bezafibrate—Hypersensitivity—Sunitinib—kidney cancer	0.000202	0.00129	CcSEcCtD
Bezafibrate—Pruritus—Sorafenib—kidney cancer	0.000202	0.00129	CcSEcCtD
Bezafibrate—Erythema multiforme—Capecitabine—kidney cancer	0.000201	0.00129	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000201	0.00128	CcSEcCtD
Bezafibrate—Rash—Erlotinib—kidney cancer	0.0002	0.00128	CcSEcCtD
Bezafibrate—Dermatitis—Erlotinib—kidney cancer	0.0002	0.00128	CcSEcCtD
Bezafibrate—Insomnia—Gemcitabine—kidney cancer	0.000199	0.00127	CcSEcCtD
Bezafibrate—Headache—Erlotinib—kidney cancer	0.000199	0.00127	CcSEcCtD
Bezafibrate—Pain—Vincristine—kidney cancer	0.000199	0.00127	CcSEcCtD
Bezafibrate—Constipation—Vincristine—kidney cancer	0.000199	0.00127	CcSEcCtD
Bezafibrate—Nausea—Vinblastine—kidney cancer	0.000196	0.00125	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—kidney cancer	0.000195	0.00125	CcSEcCtD
Bezafibrate—Nausea—Everolimus—kidney cancer	0.000195	0.00125	CcSEcCtD
Bezafibrate—Diarrhoea—Sorafenib—kidney cancer	0.000195	0.00125	CcSEcCtD
Bezafibrate—Pruritus—Sunitinib—kidney cancer	0.000194	0.00124	CcSEcCtD
Bezafibrate—Myalgia—Paclitaxel—kidney cancer	0.000192	0.00123	CcSEcCtD
Bezafibrate—Hypersensitivity—Dactinomycin—kidney cancer	0.000192	0.00122	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Vincristine—kidney cancer	0.00019	0.00121	CcSEcCtD
Bezafibrate—Dizziness—Sorafenib—kidney cancer	0.000189	0.00121	CcSEcCtD
Bezafibrate—Constipation—Gemcitabine—kidney cancer	0.000188	0.0012	CcSEcCtD
Bezafibrate—Pain—Gemcitabine—kidney cancer	0.000188	0.0012	CcSEcCtD
Bezafibrate—Nausea—Erlotinib—kidney cancer	0.000188	0.0012	CcSEcCtD
Bezafibrate—Alopecia—Capecitabine—kidney cancer	0.000188	0.0012	CcSEcCtD
Bezafibrate—Diarrhoea—Sunitinib—kidney cancer	0.000188	0.0012	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—kidney cancer	0.000187	0.069	CrCbGaD
Bezafibrate—Blood creatinine increased—Doxorubicin—kidney cancer	0.000186	0.00119	CcSEcCtD
Bezafibrate—Erythema—Capecitabine—kidney cancer	0.000185	0.00118	CcSEcCtD
Bezafibrate—Abdominal pain—Vincristine—kidney cancer	0.000184	0.00117	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000183	0.00117	CcSEcCtD
Bezafibrate—Infection—Paclitaxel—kidney cancer	0.000183	0.00117	CcSEcCtD
Bezafibrate—Flatulence—Capecitabine—kidney cancer	0.000183	0.00117	CcSEcCtD
Bezafibrate—Dizziness—Sunitinib—kidney cancer	0.000182	0.00116	CcSEcCtD
Bezafibrate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000181	0.00115	CcSEcCtD
Bezafibrate—Rash—Sorafenib—kidney cancer	0.00018	0.00115	CcSEcCtD
Bezafibrate—Dermatitis—Sorafenib—kidney cancer	0.00018	0.00115	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000179	0.00114	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000179	0.00114	CcSEcCtD
Bezafibrate—Headache—Sorafenib—kidney cancer	0.000179	0.00114	CcSEcCtD
Bezafibrate—Muscle spasms—Capecitabine—kidney cancer	0.000178	0.00114	CcSEcCtD
Bezafibrate—Diarrhoea—Dactinomycin—kidney cancer	0.000178	0.00114	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—kidney cancer	0.000176	0.00112	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—kidney cancer	0.000175	0.00112	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000175	0.00112	CcSEcCtD
Bezafibrate—Rash—Sunitinib—kidney cancer	0.000173	0.00111	CcSEcCtD
Bezafibrate—Dermatitis—Sunitinib—kidney cancer	0.000173	0.00111	CcSEcCtD
Bezafibrate—Aminohippurate—ABCB1—kidney cancer	0.000173	0.064	CrCbGaD
Bezafibrate—Headache—Sunitinib—kidney cancer	0.000172	0.0011	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—kidney cancer	0.000172	0.0011	CcSEcCtD
Bezafibrate—Anaemia—Capecitabine—kidney cancer	0.000171	0.0011	CcSEcCtD
Bezafibrate—Hypersensitivity—Vincristine—kidney cancer	0.000171	0.00109	CcSEcCtD
Bezafibrate—Nausea—Sorafenib—kidney cancer	0.00017	0.00108	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000168	0.00107	CcSEcCtD
Bezafibrate—Insomnia—Paclitaxel—kidney cancer	0.000167	0.00107	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—kidney cancer	0.000165	0.00105	CcSEcCtD
Bezafibrate—Rash—Dactinomycin—kidney cancer	0.000164	0.00105	CcSEcCtD
Bezafibrate—Nausea—Sunitinib—kidney cancer	0.000163	0.00104	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—kidney cancer	0.000163	0.00104	CcSEcCtD
Bezafibrate—Dyspepsia—Paclitaxel—kidney cancer	0.000162	0.00104	CcSEcCtD
Bezafibrate—Diarrhoea—Vincristine—kidney cancer	0.000159	0.00102	CcSEcCtD
Bezafibrate—Indomethacin—ABCB1—kidney cancer	0.000159	0.0587	CrCbGaD
Bezafibrate—Myalgia—Capecitabine—kidney cancer	0.000158	0.00101	CcSEcCtD
Bezafibrate—Constipation—Paclitaxel—kidney cancer	0.000158	0.00101	CcSEcCtD
Bezafibrate—Pain—Paclitaxel—kidney cancer	0.000158	0.00101	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000157	0.001	CcSEcCtD
Bezafibrate—Pruritus—Gemcitabine—kidney cancer	0.000156	0.000996	CcSEcCtD
Bezafibrate—Nausea—Dactinomycin—kidney cancer	0.000154	0.000986	CcSEcCtD
Bezafibrate—Dizziness—Vincristine—kidney cancer	0.000154	0.000981	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000152	0.000969	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000151	0.000964	CcSEcCtD
Bezafibrate—Diarrhoea—Gemcitabine—kidney cancer	0.000151	0.000963	CcSEcCtD
Bezafibrate—Infection—Capecitabine—kidney cancer	0.00015	0.000961	CcSEcCtD
Bezafibrate—Thrombocytopenia—Capecitabine—kidney cancer	0.000148	0.000947	CcSEcCtD
Bezafibrate—Urticaria—Paclitaxel—kidney cancer	0.000147	0.000936	CcSEcCtD
Bezafibrate—Rash—Vincristine—kidney cancer	0.000146	0.000936	CcSEcCtD
Bezafibrate—Dermatitis—Vincristine—kidney cancer	0.000146	0.000935	CcSEcCtD
Bezafibrate—Abdominal pain—Paclitaxel—kidney cancer	0.000146	0.000932	CcSEcCtD
Bezafibrate—Headache—Vincristine—kidney cancer	0.000146	0.000929	CcSEcCtD
Bezafibrate—Glyburide—ABCB1—kidney cancer	0.000143	0.053	CrCbGaD
Bezafibrate—Rash—Gemcitabine—kidney cancer	0.000139	0.000887	CcSEcCtD
Bezafibrate—Dermatitis—Gemcitabine—kidney cancer	0.000139	0.000887	CcSEcCtD
Bezafibrate—Headache—Gemcitabine—kidney cancer	0.000138	0.000882	CcSEcCtD
Bezafibrate—Nausea—Vincristine—kidney cancer	0.000138	0.000881	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000138	0.000881	CcSEcCtD
Bezafibrate—Insomnia—Capecitabine—kidney cancer	0.000137	0.000875	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—kidney cancer	0.000136	0.000871	CcSEcCtD
Bezafibrate—Hypersensitivity—Paclitaxel—kidney cancer	0.000136	0.000868	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—kidney cancer	0.000136	0.000867	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—kidney cancer	0.000135	0.00086	CcSEcCtD
Bezafibrate—Dyspepsia—Capecitabine—kidney cancer	0.000133	0.000851	CcSEcCtD
Bezafibrate—Nausea—Gemcitabine—kidney cancer	0.000131	0.000836	CcSEcCtD
Bezafibrate—Pruritus—Paclitaxel—kidney cancer	0.000131	0.000834	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—kidney cancer	0.00013	0.00083	CcSEcCtD
Bezafibrate—Constipation—Capecitabine—kidney cancer	0.000129	0.000827	CcSEcCtD
Bezafibrate—Pain—Capecitabine—kidney cancer	0.000129	0.000827	CcSEcCtD
Bezafibrate—Diarrhoea—Paclitaxel—kidney cancer	0.000126	0.000806	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000124	0.000791	CcSEcCtD
Bezafibrate—Dizziness—Paclitaxel—kidney cancer	0.000122	0.000779	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—kidney cancer	0.000121	0.000775	CcSEcCtD
Bezafibrate—Urticaria—Capecitabine—kidney cancer	0.00012	0.000768	CcSEcCtD
Bezafibrate—Abdominal pain—Capecitabine—kidney cancer	0.00012	0.000764	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—kidney cancer	0.00012	0.000764	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—kidney cancer	0.000118	0.000753	CcSEcCtD
Bezafibrate—Rash—Paclitaxel—kidney cancer	0.000116	0.000743	CcSEcCtD
Bezafibrate—Dermatitis—Paclitaxel—kidney cancer	0.000116	0.000742	CcSEcCtD
Bezafibrate—Headache—Paclitaxel—kidney cancer	0.000116	0.000738	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—kidney cancer	0.000115	0.000734	CcSEcCtD
Bezafibrate—Hypersensitivity—Capecitabine—kidney cancer	0.000112	0.000713	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—kidney cancer	0.000111	0.000706	CcSEcCtD
Bezafibrate—Nausea—Paclitaxel—kidney cancer	0.00011	0.0007	CcSEcCtD
Bezafibrate—Pruritus—Capecitabine—kidney cancer	0.000107	0.000684	CcSEcCtD
Bezafibrate—Diarrhoea—Capecitabine—kidney cancer	0.000104	0.000662	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—kidney cancer	0.000102	0.00065	CcSEcCtD
Bezafibrate—Dizziness—Capecitabine—kidney cancer	0.0001	0.00064	CcSEcCtD
Bezafibrate—Infection—Doxorubicin—kidney cancer	9.69e-05	0.000619	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—kidney cancer	9.55e-05	0.00061	CcSEcCtD
Bezafibrate—Rash—Capecitabine—kidney cancer	9.55e-05	0.00061	CcSEcCtD
Bezafibrate—Dermatitis—Capecitabine—kidney cancer	9.54e-05	0.000609	CcSEcCtD
Bezafibrate—Headache—Capecitabine—kidney cancer	9.48e-05	0.000606	CcSEcCtD
Bezafibrate—Nausea—Capecitabine—kidney cancer	8.99e-05	0.000574	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.89e-05	0.000568	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—kidney cancer	8.83e-05	0.000564	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—kidney cancer	8.59e-05	0.000549	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—kidney cancer	8.34e-05	0.000533	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—kidney cancer	8.34e-05	0.000533	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Doxorubicin—kidney cancer	7.98e-05	0.00051	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—kidney cancer	7.75e-05	0.000495	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—kidney cancer	7.71e-05	0.000493	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—kidney cancer	7.19e-05	0.000459	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—kidney cancer	6.9e-05	0.000441	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—kidney cancer	6.68e-05	0.000427	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—kidney cancer	6.45e-05	0.000412	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—kidney cancer	6.15e-05	0.000393	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—kidney cancer	6.15e-05	0.000393	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—kidney cancer	6.11e-05	0.000391	CcSEcCtD
Bezafibrate—Nausea—Doxorubicin—kidney cancer	5.8e-05	0.00037	CcSEcCtD
Bezafibrate—CYP1A1—Metabolism—PDHB—kidney cancer	3.26e-05	0.000305	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—RAF1—kidney cancer	3.26e-05	0.000305	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—POMC—kidney cancer	3.25e-05	0.000304	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—RELA—kidney cancer	3.24e-05	0.000304	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KDR—kidney cancer	3.23e-05	0.000302	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—ERBB2—kidney cancer	3.22e-05	0.000302	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.22e-05	0.000302	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC5A3—kidney cancer	3.21e-05	0.000301	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PGK1—kidney cancer	3.21e-05	0.000301	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PSMD7—kidney cancer	3.21e-05	0.0003	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—kidney cancer	3.18e-05	0.000298	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—HSPB1—kidney cancer	3.18e-05	0.000298	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—EIF4EBP1—kidney cancer	3.18e-05	0.000298	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSTP1—kidney cancer	3.17e-05	0.000297	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—SLC2A1—kidney cancer	3.17e-05	0.000297	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MET—kidney cancer	3.16e-05	0.000296	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—LDHB—kidney cancer	3.15e-05	0.000295	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.08e-05	0.000288	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CCBL1—kidney cancer	3.06e-05	0.000287	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—BCHE—kidney cancer	3.04e-05	0.000285	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—CDKN2B—kidney cancer	3.01e-05	0.000282	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.01e-05	0.000282	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ABCB1—kidney cancer	3e-05	0.000281	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SLC5A5—kidney cancer	3e-05	0.000281	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3e-05	0.000281	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PDHB—kidney cancer	2.99e-05	0.00028	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—POMC—kidney cancer	2.98e-05	0.000279	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PSMD7—kidney cancer	2.95e-05	0.000277	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CRABP1—kidney cancer	2.95e-05	0.000276	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSTM1—kidney cancer	2.92e-05	0.000273	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SLC2A1—kidney cancer	2.9e-05	0.000272	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CTNNB1—kidney cancer	2.82e-05	0.000264	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.81e-05	0.000264	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CCBL1—kidney cancer	2.81e-05	0.000263	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.77e-05	0.00026	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP1A1—kidney cancer	2.76e-05	0.000259	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—RAF1—kidney cancer	2.76e-05	0.000259	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—kidney cancer	2.76e-05	0.000258	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.76e-05	0.000258	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ITPR2—kidney cancer	2.74e-05	0.000257	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CA9—kidney cancer	2.73e-05	0.000256	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.68e-05	0.000251	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.67e-05	0.00025	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GLIPR1—kidney cancer	2.66e-05	0.000249	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPAT—kidney cancer	2.66e-05	0.000249	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—JUNB—kidney cancer	2.65e-05	0.000249	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTP1—kidney cancer	2.64e-05	0.000248	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.62e-05	0.000246	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.6e-05	0.000243	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.54e-05	0.000238	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.53e-05	0.000237	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ABCB1—kidney cancer	2.5e-05	0.000234	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTT1—kidney cancer	2.5e-05	0.000234	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ACHE—kidney cancer	2.5e-05	0.000234	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—kidney cancer	2.48e-05	0.000232	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—FH—kidney cancer	2.47e-05	0.000231	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APRT—kidney cancer	2.47e-05	0.000231	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.46e-05	0.000231	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.45e-05	0.00023	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPAT—kidney cancer	2.43e-05	0.000228	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.43e-05	0.000228	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTM1—kidney cancer	2.43e-05	0.000228	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.43e-05	0.000227	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—kidney cancer	2.42e-05	0.000227	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTP1—kidney cancer	2.42e-05	0.000227	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.41e-05	0.000226	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.4e-05	0.000225	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.38e-05	0.000223	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SCARB1—kidney cancer	2.37e-05	0.000222	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK3—kidney cancer	2.35e-05	0.00022	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS1—kidney cancer	2.34e-05	0.000219	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—RAF1—kidney cancer	2.33e-05	0.000219	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—RELA—kidney cancer	2.32e-05	0.000218	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CRABP1—kidney cancer	2.32e-05	0.000218	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPC3—kidney cancer	2.32e-05	0.000218	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ERBB2—kidney cancer	2.31e-05	0.000216	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP1A1—kidney cancer	2.3e-05	0.000216	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PSMD7—kidney cancer	2.3e-05	0.000215	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ABCB1—kidney cancer	2.29e-05	0.000214	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.27e-05	0.000213	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APRT—kidney cancer	2.26e-05	0.000212	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FH—kidney cancer	2.26e-05	0.000212	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.26e-05	0.000212	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CA2—kidney cancer	2.26e-05	0.000212	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK1—kidney cancer	2.23e-05	0.000209	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.23e-05	0.000209	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTM1—kidney cancer	2.22e-05	0.000208	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.21e-05	0.000207	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALAD—kidney cancer	2.2e-05	0.000206	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—BCHE—kidney cancer	2.18e-05	0.000204	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—CDKN2B—kidney cancer	2.16e-05	0.000202	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ITPR2—kidney cancer	2.16e-05	0.000202	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC5A5—kidney cancer	2.15e-05	0.000202	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ST3GAL2—kidney cancer	2.15e-05	0.000201	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.14e-05	0.000201	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPC3—kidney cancer	2.13e-05	0.000199	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.11e-05	0.000198	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—kidney cancer	2.11e-05	0.000198	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP1A1—kidney cancer	2.11e-05	0.000197	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDH1A1—kidney cancer	2.1e-05	0.000197	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC2A1—kidney cancer	2.08e-05	0.000195	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA2—kidney cancer	2.07e-05	0.000194	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—POMC—kidney cancer	2.06e-05	0.000193	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—kidney cancer	2.02e-05	0.000189	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALAD—kidney cancer	2.02e-05	0.000189	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.02e-05	0.000189	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PGK1—kidney cancer	2.01e-05	0.000189	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC5A3—kidney cancer	2.01e-05	0.000189	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.99e-05	0.000186	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LDHB—kidney cancer	1.97e-05	0.000185	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.97e-05	0.000185	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTT1—kidney cancer	1.97e-05	0.000184	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ACHE—kidney cancer	1.97e-05	0.000184	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.92e-05	0.00018	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.89e-05	0.000177	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ACY1—kidney cancer	1.89e-05	0.000177	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SCARB1—kidney cancer	1.86e-05	0.000175	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PGK1—kidney cancer	1.85e-05	0.000173	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.85e-05	0.000173	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS1—kidney cancer	1.84e-05	0.000173	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LDHB—kidney cancer	1.81e-05	0.00017	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PSMD7—kidney cancer	1.81e-05	0.00017	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—kidney cancer	1.78e-05	0.000167	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.76e-05	0.000165	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—kidney cancer	1.74e-05	0.000163	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTP1—kidney cancer	1.73e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.73e-05	0.000162	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—POMC—kidney cancer	1.72e-05	0.000161	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—BCHE—kidney cancer	1.71e-05	0.000161	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CA9—kidney cancer	1.71e-05	0.00016	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.69e-05	0.000159	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK3—kidney cancer	1.68e-05	0.000158	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—kidney cancer	1.64e-05	0.000154	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—kidney cancer	1.64e-05	0.000154	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000153	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PDHB—kidney cancer	1.6e-05	0.00015	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK1—kidney cancer	1.6e-05	0.00015	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—POMC—kidney cancer	1.6e-05	0.00015	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTM1—kidney cancer	1.59e-05	0.000149	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.59e-05	0.000149	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MAPK3—kidney cancer	1.58e-05	0.000148	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—POMC—kidney cancer	1.57e-05	0.000147	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA9—kidney cancer	1.57e-05	0.000147	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.56e-05	0.000146	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.53e-05	0.000144	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—kidney cancer	1.53e-05	0.000144	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—kidney cancer	1.51e-05	0.000142	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP1A1—kidney cancer	1.51e-05	0.000141	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CCBL1—kidney cancer	1.51e-05	0.000141	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CRABP1—kidney cancer	1.46e-05	0.000136	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—kidney cancer	1.43e-05	0.000134	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.38e-05	0.00013	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—kidney cancer	1.37e-05	0.000128	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.36e-05	0.000128	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ITPR2—kidney cancer	1.35e-05	0.000127	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CRABP1—kidney cancer	1.33e-05	0.000125	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.31e-05	0.000122	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPAT—kidney cancer	1.31e-05	0.000122	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.29e-05	0.000121	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—kidney cancer	1.25e-05	0.000117	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—kidney cancer	1.25e-05	0.000117	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.25e-05	0.000117	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ITPR2—kidney cancer	1.24e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.24e-05	0.000116	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ACHE—kidney cancer	1.23e-05	0.000116	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTT1—kidney cancer	1.23e-05	0.000116	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FH—kidney cancer	1.22e-05	0.000114	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APRT—kidney cancer	1.22e-05	0.000114	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK3—kidney cancer	1.2e-05	0.000112	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—kidney cancer	1.19e-05	0.000112	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.19e-05	0.000111	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SCARB1—kidney cancer	1.17e-05	0.000109	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—kidney cancer	1.17e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS1—kidney cancer	1.16e-05	0.000108	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.14e-05	0.000107	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPC3—kidney cancer	1.14e-05	0.000107	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMD7—kidney cancer	1.13e-05	0.000106	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTT1—kidney cancer	1.13e-05	0.000106	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ACHE—kidney cancer	1.13e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—POMC—kidney cancer	1.13e-05	0.000105	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA2—kidney cancer	1.11e-05	0.000104	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—kidney cancer	1.09e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALAD—kidney cancer	1.08e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BCHE—kidney cancer	1.07e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SCARB1—kidney cancer	1.07e-05	0.0001	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC5A5—kidney cancer	1.06e-05	9.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS1—kidney cancer	1.06e-05	9.93e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.06e-05	9.91e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMD7—kidney cancer	1.04e-05	9.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.03e-05	9.68e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A1—kidney cancer	1.03e-05	9.61e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—kidney cancer	1.01e-05	9.48e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.95e-06	9.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.91e-06	9.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PGK1—kidney cancer	9.91e-06	9.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BCHE—kidney cancer	9.85e-06	9.23e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.76e-06	9.15e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC5A5—kidney cancer	9.73e-06	9.12e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LDHB—kidney cancer	9.71e-06	9.1e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A1—kidney cancer	9.4e-06	8.81e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.12e-06	8.55e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—kidney cancer	8.98e-06	8.41e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—POMC—kidney cancer	8.86e-06	8.3e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.68e-06	8.13e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK3—kidney cancer	8.6e-06	8.06e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—kidney cancer	8.55e-06	8.01e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—kidney cancer	8.43e-06	7.9e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA9—kidney cancer	8.42e-06	7.89e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—kidney cancer	8.37e-06	7.84e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—kidney cancer	8.09e-06	7.59e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.95e-06	7.45e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—kidney cancer	7.86e-06	7.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—kidney cancer	7.84e-06	7.35e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—kidney cancer	7.83e-06	7.34e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—kidney cancer	7.71e-06	7.22e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—kidney cancer	7.42e-06	6.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—kidney cancer	7.2e-06	6.75e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CRABP1—kidney cancer	7.16e-06	6.71e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—kidney cancer	7.07e-06	6.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1A1—kidney cancer	6.83e-06	6.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ITPR2—kidney cancer	6.66e-06	6.24e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—kidney cancer	6.16e-06	5.78e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.12e-06	5.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTT1—kidney cancer	6.07e-06	5.69e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ACHE—kidney cancer	6.07e-06	5.69e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SCARB1—kidney cancer	5.75e-06	5.39e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS1—kidney cancer	5.69e-06	5.33e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.61e-06	5.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMD7—kidney cancer	5.58e-06	5.23e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—POMC—kidney cancer	5.55e-06	5.2e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—kidney cancer	5.52e-06	5.18e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BCHE—kidney cancer	5.29e-06	4.96e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.22e-06	4.9e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—POMC—kidney cancer	5.09e-06	4.77e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.05e-06	4.73e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—kidney cancer	4.43e-06	4.15e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—kidney cancer	4.35e-06	4.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—kidney cancer	4.21e-06	3.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—kidney cancer	4.06e-06	3.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—kidney cancer	3.98e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—kidney cancer	3.87e-06	3.62e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—kidney cancer	3.86e-06	3.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.67e-06	3.44e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—kidney cancer	3.54e-06	3.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—POMC—kidney cancer	2.73e-06	2.56e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—kidney cancer	2.73e-06	2.55e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.5e-06	2.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—kidney cancer	2.18e-06	2.04e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—kidney cancer	1.9e-06	1.78e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.34e-06	1.26e-05	CbGpPWpGaD
